Kesimpta Europeiska unionen - slovakiska - EMA (European Medicines Agency)

kesimpta

novartis ireland ltd - ofatumumab - roztrúsená skleróza, recidivujúce-odosielajúcej - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Ngenla Europeiska unionen - slovakiska - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - hypofÝzy a hypotalamickÝch hormÓny a ich analÓgy - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Ebglyss Europeiska unionen - slovakiska - EMA (European Medicines Agency)

ebglyss

almirall, s.a. - lebrikizumab - dermatitída, atopická - ostatné dermatologické prípravky - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.

PROTHROMPLEX NF 600 IU Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

prothromplex nf 600 iu

baxalta innovations gmbh, rakúsko - koagulačné faktory ix, ii, vii a x v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Gemcitabín SUN 10 mg/ml infúzny roztok Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

gemcitabín sun 10 mg/ml infúzny roztok

sun pharmaceutical industries europe b.v. , holandsko - gemcitabín - 44 - cytostatica

LUNA EXPERIENCE Slovakien - slovakiska - myHealthbox

luna experience

bayer ag - dispergovateľný koncentrát - fluopyram 200 g/l; tebuconazole 200 g/l

Vyepti Europeiska unionen - slovakiska - EMA (European Medicines Agency)

vyepti

h. lundbeck a/s - eptinezumab - poruchy migrény - analgetiká - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.